Your browser doesn't support javascript.
loading
Kynurenine increases matrix metalloproteinase-1 and -3 expression in cultured dermal fibroblasts and improves scarring in vivo.
Li, Yunyuan; Kilani, Ruhangiz T; Rahmani-Neishaboor, Elham; Jalili, Reza B; Ghahary, Aziz.
Afiliación
  • Li Y; Department of Surgery, BC Professional Burn and Wound Healing Research Laboratory, University of British Columbia, Vancouver, British Columbia, Canada.
  • Kilani RT; Department of Surgery, BC Professional Burn and Wound Healing Research Laboratory, University of British Columbia, Vancouver, British Columbia, Canada.
  • Rahmani-Neishaboor E; Department of Surgery, BC Professional Burn and Wound Healing Research Laboratory, University of British Columbia, Vancouver, British Columbia, Canada.
  • Jalili RB; Department of Surgery, BC Professional Burn and Wound Healing Research Laboratory, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ghahary A; Department of Surgery, BC Professional Burn and Wound Healing Research Laboratory, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: aghahary@mail.ubc.ca.
J Invest Dermatol ; 134(3): 643-650, 2014 Mar.
Article en En | MEDLINE | ID: mdl-23877570
We previously demonstrated that the formation of hypertrophic scarring on the wounds of a rabbit ear fibrotic model was significantly reduced by grafting a bilayer skin substitute expressing indoleamine 2,3-dioxygenase (IDO). Here, we hypothesize that the improved healing quality is due to extracellular matrix modulatory effect of IDO-mediated tryptophan metabolites. To test this hypothesis, a series of in vitro and in vivo experiments were conducted and the findings revealed a significant increase in the expression of matrix metalloproteinase 1 (MMP-1) in fibroblasts either transduced with human IDO gene or cultured with conditioned media obtained from IDO-expressing cells. Consistent with this finding, kynurenine (Kyn) treatment markedly increased the levels of MMP-1 and MMP-3 expression through activation of the MEK (mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase)-ERK1/2 MAPK signaling pathway. On the other hand, Kyn significantly suppressed the expression of type I collagen in fibroblasts as compared with that of control. To test the anti-fibrogenic effect of Kyn in an in vivo model, rabbit ear fibrotic wounds were topically treated with cream containing 50 µg Kyn per l00 µl of cream per wound. The result showed a marked improvement in scar formation relative to the controls. These findings collectively suggest that Kyn can potentially be used as an anti-fibrogenic agent for treating hypertrophic scarring.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cicatriz Hipertrófica / Metaloproteinasa 3 de la Matriz / Dermis / Metaloproteinasa 1 de la Matriz / Fármacos Dermatológicos / Quinurenina Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Invest Dermatol Año: 2014 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cicatriz Hipertrófica / Metaloproteinasa 3 de la Matriz / Dermis / Metaloproteinasa 1 de la Matriz / Fármacos Dermatológicos / Quinurenina Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Invest Dermatol Año: 2014 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos